歩行補助器市場：タイプ別、エンドユーザー別-2025-2030年の世界予測

歩行補助器市場の2023年の市場規模は26億9,000万米ドルで、2024年には29億米ドルに達すると予測され、CAGR 7.95％で成長し、2030年には46億米ドルに達すると予測されています。

歩行補助器市場は現在、高齢化、移動に関連する障害の有病率の増加、支援技術の進歩に関する要因が複雑に絡み合って牽引しています。歩行補助器は、杖、松葉杖、歩行器などの器具を含み、一時的または永続的な運動障害を持つ人の移動と自立を強化する必要性に応えるものです。ヘルスケア施設、リハビリセンター、高齢者や手術、怪我、移動に影響を及ぼす病状から回復した人による個人使用など、用途は多岐にわたる。主な成長要因としては、軽量化、耐久性の向上、使いやすい設計につながった技術の進歩、理学療法やリハビリテーションに対する意識の高まりなどが挙げられます。同市場における潜在的なビジネスチャンスは、ユーザーの活動や健康をモニターするセンサーを搭載したパーソナライズされたスマートな歩行補助器や、高齢化がますます顕著になっている新興市場への進出にあります。とはいえ、先進的な歩行補助器の高価格、限られた償還政策、補助具の使用に関連するユーザーの不快感やスティグマによるアドヒアランスのばらつきといった課題が、市場の成長を妨げています。成長を活かすためには、より費用対効果が高く快適な製品を生み出すための材料科学における継続的なイノベーションが不可欠です。さらに、デジタルヘルス技術を統合することで、遠隔モニタリングや補助の道が開ける可能性があります。人間工学に基づいて設計された補助具や、ユーザー固有のカスタマイズに関する調査といった新たな動向は、有望なイノベーションの道を明らかにするものです。組織は、流通とアクセシビリティを強化するために、消費者教育とヘルスケア・プロバイダーとのパートナーシップ拡大に注力すべきです。歩行補助器市場はダイナミックで進化する性質を示し、スマート技術や持続可能な素材の研究開発には大きな可能性があります。市場のプレゼンスを維持し、拡大を推進するためには、競争力のある価格設定とこれらの分野への戦略的投資が推奨されます。

市場力学：急速に進化する歩行補助器市場の主要市場インサイトを公開

歩行補助器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 高齢者人口の増加と肥満人口の増加
  • 関節炎とパーキンソン病の罹患率の上昇
  • 有利な政府政策と政策
• 市場抑制要因
  • 製品コストの高さ
• 市場機会
  • 歩行補助器のカスタマイズによる強固な技術進歩
  • 製品改良のための新たな研究開発活動
• 市場の課題
  • 市場における低品質製品の入手可能性

ポーターの5つの力：歩行補助器市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：歩行補助器市場における外部からの影響の把握

外部マクロ環境要因は、歩行補助器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析歩行補助器市場における競合情勢の把握

歩行補助器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス歩行補助器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、歩行補助器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨歩行補助器市場における成功への道筋を描く

歩行補助器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢者人口の増加と肥満の増加
    • 関節炎とパーキンソン病の発症率の上昇
    • 政府の好ましい政策と規制
  • 抑制要因
    • 製品のコストが高い
  • 機会
    • 歩行補助器のカスタマイズによる強力な技術的進歩
    • 製品の改善に向けた新たな研究開発活動
  • 課題
    • 市場における低品質製品の入手可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 歩行補助器市場：タイプ別

• 杖
  • 多脚杖
  • 一本杖
• 松葉杖
  • 腋窩または脇の下の松葉杖
  • 前腕用松葉杖
  • ガタークラッチ
• 歩行器
• ウォーカー

第7章 歩行補助器市場：エンドユーザー別

• 障害者
• お年寄り

第8章 南北アメリカの歩行補助器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の歩行補助器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの歩行補助器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 21st century scientific Inc
• Amigo Mobility International Inc.
• Benmor Medical
• Briggs Healthcare
• Eurovema Mobility AB
• Evolution Technologies Inc.
• GF Health Products, Inc.
• HUMAN CARE GROUP
• Invacare Corporation
• Karman Healthcare Inc
• MATSUNAGA MANUFACTORY Co., Ltd.
• Medical Depot, Inc.
• Otto Bock Australia Pty. Ltd.
• Patterson Medical Holdings Inc.
• Pride mobility products corp
• Stryker Corporation
• Sunrise Medical, Inc.
• Topro Industrie AS

LIST OF FIGURES

• FIGURE 1. WALKING AIDS MARKET RESEARCH PROCESS
• FIGURE 2. WALKING AIDS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL WALKING AIDS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL WALKING AIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL WALKING AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL WALKING AIDS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL WALKING AIDS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL WALKING AIDS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL WALKING AIDS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS WALKING AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS WALKING AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES WALKING AIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES WALKING AIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC WALKING AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC WALKING AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA WALKING AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA WALKING AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. WALKING AIDS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. WALKING AIDS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. WALKING AIDS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL WALKING AIDS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL WALKING AIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL WALKING AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. WALKING AIDS MARKET DYNAMICS
• TABLE 7. GLOBAL WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL WALKING AIDS MARKET SIZE, BY CANE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL WALKING AIDS MARKET SIZE, BY MULTIPLE-LEGGED CANE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL WALKING AIDS MARKET SIZE, BY SINGLE CANE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL WALKING AIDS MARKET SIZE, BY CRUTCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL WALKING AIDS MARKET SIZE, BY AXILLA OR UNDERARM CRUTCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL WALKING AIDS MARKET SIZE, BY FOREARM CRUTCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL WALKING AIDS MARKET SIZE, BY GUTTER CRUTCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL WALKING AIDS MARKET SIZE, BY ROLLATOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL WALKING AIDS MARKET SIZE, BY WALKER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL WALKING AIDS MARKET SIZE, BY DISABLED PERSON, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL WALKING AIDS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS WALKING AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. CANADA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 37. CANADA WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 38. CANADA WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES WALKING AIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC WALKING AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. CHINA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. CHINA WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 59. CHINA WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 60. CHINA WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. INDIA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. INDIA WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 63. INDIA WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 64. INDIA WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA WALKING AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. ITALY WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. ITALY WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 132. ITALY WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 133. ITALY WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. POLAND WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. POLAND WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 148. POLAND WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 149. POLAND WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. QATAR WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. QATAR WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 152. QATAR WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 153. QATAR WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM WALKING AIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM WALKING AIDS MARKET SIZE, BY CANE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM WALKING AIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. WALKING AIDS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 191. WALKING AIDS MARKET, FPNV POSITIONING MATRIX, 2023

The Walking Aids Market was valued at USD 2.69 billion in 2023, expected to reach USD 2.90 billion in 2024, and is projected to grow at a CAGR of 7.95%, to USD 4.60 billion by 2030.

The walking aids market is currently driven by a complex interplay of factors concerning the aging population, increasing prevalence of mobility-related disorders, and advancements in assistive technology. Walking aids, encompassing devices like canes, crutches, and walkers, serve the necessity of enhancing mobility and independence for individuals with temporary or permanent mobility impairments. The application extends across healthcare facilities, rehabilitation centers, and individual use by the elderly or those recovering from surgeries, injuries, or medical conditions affecting their mobility. Key growth influencers include technological advancements, which have led to lighter, more durable, and user-friendly designs, and the rising awareness around physical therapy and rehabilitation. Potential opportunities within the market lie in personalized, smart walking aids equipped with sensors to monitor user activity and health, as well as expanding into emerging markets where aging demographics are becoming increasingly significant. Nevertheless, the market growth is hindered by challenges such as high costs of advanced walking aids, limited reimbursement policies, and the variability in adherence due to user discomfort or stigma associated with aid usage. To capitalize on growth, continuous innovation in material science to create more cost-effective and comfortable products is essential. Moreover, integrating digital health technologies could open pathways in remote monitoring and assistance. Emerging trends like ergonomically designed aids and research into user-specific customization reveal promising innovation avenues. Organizations should focus on consumer education and expanded partnerships with healthcare providers to enhance distribution and accessibility. The walking aids market demonstrates a dynamic and evolving nature, with significant potential for R&D in smart technologies and sustainable materials. As such, strategic investments in these areas, combined with competitive pricing, are recommended to sustain market presence and drive expansion.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Walking Aids Market

The Walking Aids Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing elderly population and rise in obesity among population
  • Rising incidence of arthritis and Parkinson's disease
  • Favorable government policies and regulations
• Market Restraints
  • High cost of the product
• Market Opportunities
  • Robust technological advancements with customization of walking aids
  • Emerging research and development activities to improvise the product
• Market Challenges
  • Availability of low quality products in the market

Porter's Five Forces: A Strategic Tool for Navigating the Walking Aids Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Walking Aids Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Walking Aids Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Walking Aids Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Walking Aids Market

A detailed market share analysis in the Walking Aids Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Walking Aids Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Walking Aids Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Walking Aids Market

A strategic analysis of the Walking Aids Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Walking Aids Market, highlighting leading vendors and their innovative profiles. These include 21st century scientific Inc, Amigo Mobility International Inc., Benmor Medical, Briggs Healthcare, Eurovema Mobility AB, Evolution Technologies Inc., GF Health Products, Inc., HUMAN CARE GROUP, Invacare Corporation, Karman Healthcare Inc, MATSUNAGA MANUFACTORY Co., Ltd., Medical Depot, Inc., Otto Bock Australia Pty. Ltd., Patterson Medical Holdings Inc., Pride mobility products corp, Stryker Corporation, Sunrise Medical, Inc., and Topro Industrie AS.

Market Segmentation & Coverage

This research report categorizes the Walking Aids Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Cane, Crutch, Rollator, and Walker. The Cane is further studied across Multiple-Legged Cane and Single Cane. The Crutch is further studied across Axilla or Underarm Crutch, Forearm Crutch, and Gutter Crutch.
• Based on End-User, market is studied across Disabled Person and Elderly.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing elderly population and rise in obesity among population
    • 5.1.1.2. Rising incidence of arthritis and Parkinson's disease
    • 5.1.1.3. Favorable government policies and regulations
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of the product
  • 5.1.3. Opportunities
    • 5.1.3.1. Robust technological advancements with customization of walking aids
    • 5.1.3.2. Emerging research and development activities to improvise the product
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of low quality products in the market
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Walking Aids Market, by Type

• 6.1. Introduction
• 6.2. Cane
  • 6.2.1. Multiple-Legged Cane
  • 6.2.2. Single Cane
• 6.3. Crutch
  • 6.3.1. Axilla or Underarm Crutch
  • 6.3.2. Forearm Crutch
  • 6.3.3. Gutter Crutch
• 6.4. Rollator
• 6.5. Walker

7. Walking Aids Market, by End-User

• 7.1. Introduction
• 7.2. Disabled Person
• 7.3. Elderly

8. Americas Walking Aids Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Walking Aids Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Walking Aids Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 21st century scientific Inc
• 2. Amigo Mobility International Inc.
• 3. Benmor Medical
• 4. Briggs Healthcare
• 5. Eurovema Mobility AB
• 6. Evolution Technologies Inc.
• 7. GF Health Products, Inc.
• 8. HUMAN CARE GROUP
• 9. Invacare Corporation
• 10. Karman Healthcare Inc
• 11. MATSUNAGA MANUFACTORY Co., Ltd.
• 12. Medical Depot, Inc.
• 13. Otto Bock Australia Pty. Ltd.
• 14. Patterson Medical Holdings Inc.
• 15. Pride mobility products corp
• 16. Stryker Corporation
• 17. Sunrise Medical, Inc.
• 18. Topro Industrie AS